These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35040606)

  • 1. Survey for Government Policies Regarding Strategies for the Commercialization and Globalization of Digital Therapeutics.
    Kim SY; Moon JY; Shin J; Sim JY; Kim M; Jang J
    Yonsei Med J; 2022 Jan; 63(Suppl):S56-S62. PubMed ID: 35040606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stakeholders' Perceptions Regarding Digital Therapeutics Reimbursement in South Korea: Qualitative Study.
    Sim B; Ju JH; Kim B; Lee JY
    JMIR Mhealth Uhealth; 2023 Oct; 11():e47407. PubMed ID: 37933414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citizens' Adherence to COVID-19 Mitigation Recommendations by the Government: A 3-Country Comparative Evaluation Using Web-Based Cross-Sectional Survey Data.
    Al-Hasan A; Yim D; Khuntia J
    J Med Internet Res; 2020 Aug; 22(8):e20634. PubMed ID: 32716896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for Promoting the Medical Device Industry in Korea: An Analytical Hierarchy Process Analysis.
    Lee M
    Int J Environ Res Public Health; 2018 Nov; 15(12):. PubMed ID: 30486365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Globalization, first-foods systems transformations and corporate power: a synthesis of literature and data on the market and political practices of the transnational baby food industry.
    Baker P; Russ K; Kang M; Santos TM; Neves PAR; Smith J; Kingston G; Mialon M; Lawrence M; Wood B; Moodie R; Clark D; Sievert K; Boatwright M; McCoy D
    Global Health; 2021 May; 17(1):58. PubMed ID: 34020657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KT&G: From Korean monopoly to 'a global name in the tobacco industry'.
    Lee K; Gong L; Eckhardt J; Holden C; Lee S
    Glob Public Health; 2017 Mar; 12(3):300-314. PubMed ID: 28139963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparative Study on Intention to Use Digital Therapeutics: MZ Generation and Baby Boomers' Digital Therapeutics Use Intention in Korea.
    Kim S; Eom J; Shim J
    Int J Environ Res Public Health; 2022 Aug; 19(15):. PubMed ID: 35954906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal study of the impact of three major regulations on the Korean pharmaceutical industry in the last 30 years.
    Um SI; Sohn UD; Jung SY; You SH; Kim C; Lee S; Lee H
    Health Res Policy Syst; 2022 Jan; 20(1):4. PubMed ID: 34991612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reimbursement of Digital Therapeutics: Future Perspectives in Korea.
    Ju JH; Sim B; Lee J; Lee JY
    Korean Circ J; 2022 Apr; 52(4):265-279. PubMed ID: 35388995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creating demand for foreign brands in a 'home run' market: tobacco company tactics in South Korea following market liberalisation.
    Lee S; Lee K; Holden C
    Tob Control; 2014 May; 23(3):e8. PubMed ID: 23152099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of digital therapeutics.
    Hong JS; Wasden C; Han DH
    Comput Methods Programs Biomed; 2021 Sep; 209():106319. PubMed ID: 34364181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The worldwide trend of using botanical drugs and strategies for developing global drugs.
    Ahn K
    BMB Rep; 2017 Mar; 50(3):111-116. PubMed ID: 27998396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bilingual systematic review of South Korean medical tourism: a need to rethink policy and priorities for public health?
    Xu Q; Purushothaman V; Cuomo RE; Mackey TK
    BMC Public Health; 2021 Apr; 21(1):658. PubMed ID: 33823817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
    Jeon J; Kim H; Yu KS
    J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does globalization affect COVID-19 responses?
    Bickley SJ; Chan HF; Skali A; Stadelmann D; Torgler B
    Global Health; 2021 May; 17(1):57. PubMed ID: 34016146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding how and why health is integrated into foreign policy - a case study of health is global, a UK Government Strategy 2008-2013.
    Gagnon ML; Labonté R
    Global Health; 2013 Jun; 9():24. PubMed ID: 23742130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital Health Policy and Programs for Hospital Care in Vietnam: Scoping Review.
    Tran DM; Thwaites CL; Van Nuil JI; McKnight J; Luu AP; Paton C;
    J Med Internet Res; 2022 Feb; 24(2):e32392. PubMed ID: 35138264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
    Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
    Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transparency in relations between multinational R&D pharmaceutical companies' corporate social responsibility activities and patient organizations in the Europe, Japan, and the United States].
    Kato M; Ishikawa H; Okuhara T; Kiuchi T
    Nihon Koshu Eisei Zasshi; 2019; 66(12):746-755. PubMed ID: 31875625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.